These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23170004)

  • 1. Origins of medical innovation: the case of coronary artery stents.
    Tomaselli GF
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):741-2. PubMed ID: 23170004
    [No Abstract]   [Full Text] [Related]  

  • 2. Can start-ups finish up?
    Simonton CA
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):739-40. PubMed ID: 23170003
    [No Abstract]   [Full Text] [Related]  

  • 3. Origins of medical innovation: the case of coronary artery stents.
    Xu S; Avorn J; Kesselheim AS
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):743-9. PubMed ID: 23093563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "They've gone about as far as they can go".
    King SB
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1202-3. PubMed ID: 25341712
    [No Abstract]   [Full Text] [Related]  

  • 5. Is There a Future for Diagnostic Coronary Angiography?
    King SB
    Cardiovasc Revasc Med; 2019 Nov; 20(11):1036. PubMed ID: 31865977
    [No Abstract]   [Full Text] [Related]  

  • 6. Stenting: the Latest Frontier in Percutaneous Intervention.
    Kleiman N
    Methodist Debakey Cardiovasc J; 2018; 14(1):5-6. PubMed ID: 29623166
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes.
    Jing J
    Cardiovasc J Afr; 2014; 25(5):249. PubMed ID: 25629542
    [No Abstract]   [Full Text] [Related]  

  • 8. 40 Years of Percutaneous Coronary Intervention: A Historical Remark on the Development and Evolution of Guidewire Technology.
    Kaltenbach M
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2582-2583. PubMed ID: 29268889
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of clinical benefit of drug-eluting compared to bare-metal stents for treatment of transplant coronary artery disease: why we do not need drug-eluting stents?
    Fernandez-Pereira C; Mieres J; Rodriguez AE
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):237. PubMed ID: 23073903
    [No Abstract]   [Full Text] [Related]  

  • 10. Full-metal jacket: A bad strategy.
    Alvarez JR; Quiroga JS; Lopez LR; Bauza AG; Cereijo JM; Taboada CR
    Asian Cardiovasc Thorac Ann; 2014 Jul; 22(6):737-8. PubMed ID: 24887818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-Stent Dissection Causes No Flow During Percutaneous Coronary Intervention.
    Yashima F; Yuasa S; Maekawa Y; Kimura M; Akita K; Yanagisawa R; Tanaka M; Hayashida K; Kawakami T; Kanazawa H; Fujita J; Fukuda K
    JACC Cardiovasc Interv; 2016 Jan; 9(1):102-103. PubMed ID: 26685075
    [No Abstract]   [Full Text] [Related]  

  • 12. The future of bioresorbable vascular scaffolds: niche or workhorse devices?
    Lahoud R; Ellis S
    Coron Artery Dis; 2017 Sep; 28(6):449-451. PubMed ID: 28644214
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct stenting: soft endpoints are enough.
    Earl TJ; Abbott JD
    Catheter Cardiovasc Interv; 2013 May; 81(6):957-8. PubMed ID: 23606490
    [No Abstract]   [Full Text] [Related]  

  • 14. I know what the studies say, but what should I do for my patient?
    Kurlansky P
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1310-1. PubMed ID: 25791944
    [No Abstract]   [Full Text] [Related]  

  • 15. Can we bear another bare-metal stent study?
    Yong AS; Tremmel JA
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1095-6. PubMed ID: 23704063
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioresorbable Stents: Is This Where We Are Headed?
    Wayangankar SA; Ellis SG
    Prog Cardiovasc Dis; 2015; 58(3):342-55. PubMed ID: 26319497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provisional side branch-stenting for coronary bifurcation lesions: evidence of improving procedural and clinical outcomes with contemporary techniques.
    Mylotte D; Routledge H; Harb T; Garot P; Hovasse T; Benamer H; Unterseeh T; Chevalier B; Morice MC; Louvard Y; Lefèvre T
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E437-45. PubMed ID: 23441082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    Giustino G; Mastoris I; Baber U; Sartori S; Stone GW; Leon MB; Serruys PW; Kastrati A; Windecker S; Valgimigli M; Dangas GD; Von Birgelen C; Smits PC; Kandzari D; Galatius S; Wijns W; Steg PG; Stefanini GG; Aquino M; Morice MC; Camenzind E; Weisz G; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Chieffo A; Mehran R
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1890-901. PubMed ID: 27659564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary in-stent restenosis in patients treated with thoracic external beam radiation for cancer.
    Montone RA; Minelli S; Niccoli G
    JACC Cardiovasc Interv; 2015 Apr; 8(4):641. PubMed ID: 25907094
    [No Abstract]   [Full Text] [Related]  

  • 20. Research in China: from imitation to innovation.
    King SB
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1460-1. PubMed ID: 25523539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.